FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

12776811000001104: Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
44967501000001114 Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100990101000001114 Octreotide 50micrograms/1ml solution for injection vials (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Is a Octreotide 50micrograms/1ml solution for injection vials true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has active ingredient Octreotide acetate false Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has active ingredient Octreotide true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Is pack of False Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has AMP True Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start